Collegium Pharmaceutical, Inc.

Contributing Author

Recent Articles by Collegium Pharmaceutical, Inc.

Aug-06	Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress COLL -18.55% GlobeNewswire
Jul-23	Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026 COLL GlobeNewswire
Jul-20	Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston COLL GlobeNewswire
Jun-05	Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) COLL GlobeNewswire
May-27	Collegium to Participate in 2026 Jefferies Global Healthcare Conference COLL GlobeNewswire
May-12	Collegium Completes Acquisition of AZSTARYS from Corium Therapeutics COLL GlobeNewswire
May-07	Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress COLL +7.72% GlobeNewswire
Apr-23	Collegium to Report First Quarter 2026 Financial Results on May 7, 2026 COLL GlobeNewswire
Apr-08	Collegium to Participate in Upcoming Investor Conferences COLL GlobeNewswire
Mar-19	Collegium to Acquire AZSTARYS from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory COLL GlobeNewswire
Mar-05	Collegium to Present New Real-World Data at PainConnect 2026 COLL -5.88% GlobeNewswire
Mar-03	Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community COLL GlobeNewswire
Mar-02	Collegium to Participate in Upcoming Investor Conferences COLL GlobeNewswire
Feb-26	Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results COLL GlobeNewswire
Feb-23	Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical COLL GlobeNewswire
Feb-12	Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026 COLL GlobeNewswire
Jan-15	Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference COLL GlobeNewswire
Jan-08	Collegium Provides 2026 Financial Guidance and Business Update COLL GlobeNewswire
Dec-30	Collegium Announces the Closing of $980 Million Syndicated Credit Facility COLL GlobeNewswire
Nov-12	Collegium to Participate in Upcoming Investor Conferences COLL +5.60% GlobeNewswire
Nov-06	Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance COLL +13.42% GlobeNewswire
Oct-29	Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment COLL GlobeNewswire
Oct-23	Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025 COLL GlobeNewswire
Oct-22	Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences COLL GlobeNewswire
Oct-13	Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing COLL GlobeNewswire
Aug-28	Collegium to Participate in Upcoming Investor Conferences COLL GlobeNewswire
Aug-25	Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting COLL GlobeNewswire
Aug-07	Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook COLL +10.72% GlobeNewswire
Jul-24	Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 COLL GlobeNewswire
Jul-07	Collegium Announces $150 Million Share Repurchase Program COLL GlobeNewswire
May-19	Collegium to Participate in Upcoming Investor Conferences COLL GlobeNewswire
May-12	Collegium Announces $25 Million Accelerated Share Repurchase Program COLL GlobeNewswire
May-08	Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress COLL COLL +5.94% GlobeNewswire

Collegium Pharmaceutical, Inc.

Recent Articles by Collegium Pharmaceutical, Inc.

Upgrade your Finviz experience